The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 5 Ways to Improve Your Collaboration with Orthopedic Surgeons

5 Ways to Improve Your Collaboration with Orthopedic Surgeons

August 17, 2018 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“These medications are effective for controlling symptoms and preventing disease progression. Unfortunately, they also can interfere [with] and slow down surgical incision healing after surgery and can be associated with increased infection risk for joint replacement surgery,” says orthopedic surgeon Amer Mirza, MD, co-founder, Go To Ortho, Lake Oswego, Ore. The ortho­pedic surgeons interviewed for this article rely heavily on their rheumatologist colleagues to provide guidance on when to stop medications before surgery.

You Might Also Like
  • 3 Ways to Improve How You Work with Doctors from Other Specialties
  • Chart a New Course: A Rheumatologist Talks about Practicing in an Orthopedic Environment
  • ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)
Explore this issue
August 2018
Also by this Author
  • Lupus Nephritis Improvements: A 5-Decade Retrospective Review

Guidance may vary for each individual patient, but generally speaking, Dr. Rapoport stops biologic medications for two half-lives before surgery and sometimes two half-lives after. Metho­trexate is not always stopped before surgery. Non-steroidal anti-inflammatory drugs (NSAIDs) are typically stopped five half-lives preoperatively, he added.

Most patients will not have a bad disease flare during the brief time they are off their medications, Dr. Rapoport says. In fact, it’s important the patient have their disease under control even as surgery is in the planning stages, Dr. Sayeed says. “If there is active disease, especially in someone with RA, we discourage them from having surgery because [surgery has been] shown to cause more infection and inflammation. We tend to recommend holding off on surgery until the disease is more controlled or in remission prior to surgery,” she says.

At the Center for Advanced Orthopaedics/Mid-Maryland Musculoskeletal Institute, Frederick, Md., rheumatologists and ortho­pedic physicians are both on staff and work together to plan when to stop medication use, says orthopedic surgeon Matthew J. Levine, MD. “Once we get surgical recovery done, we continue disease management with the rheumatologist,” he says.

It’s also important to let the surgeon know what medications the patient was using prior to surgery and when they were stopped. For example, sometimes a patient who has used steroids in the six months before surgery may need stress-steroid dosing in the operating room to avoid adrenal issues, Dr. Reznik says.

Surgical timing can also be a concern if a patient receives extra-articular corticosteroid injections, Dr. Reznik says. Mounting evidence shows these injections could increase the risk for infection during surgery if they were done three to six months prior to knee or hip surgery. During the waiting time between injections and surgery, Dr. Reznik may recommend other treatments, such as NSAID use, icing, bracing, strengthening and decreased use of impact load activities, such as jumping and running.

Some patients with joint disease require special care during surgery itself. “Bone quality is often poor and osteopenic, requiring gentle manipulation and hammering,” Dr. Baez says. “It is more likely in these cases to consider cementing components because of poor quality bone.”

Pages: 1 2 3 4 5 Single Page

Filed Under: Patient Perspective, Practice Management Tagged With: collaboration, communication, interdisciplinaryIssue: August 2018

You Might Also Like:
  • 3 Ways to Improve How You Work with Doctors from Other Specialties
  • Chart a New Course: A Rheumatologist Talks about Practicing in an Orthopedic Environment
  • ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)
  • Joint Surgery

Comments

  1. David Korman says

    August 26, 2018 at 5:56 pm

    You mention in your article that mounting evidence suggests that extra-articular steroid injections may increase the risk of peri-operative infection for 3-6 months. I could not find such a citation. Please direct me to these studies. Thank you.

    Reply
    • Keri Losavio says

      September 10, 2018 at 3:27 pm

      According to the author, the information was originally given to her by one of her sources for the article. He pointed her to the following: Steroid injections too soon before joint replacement may increase infection risk
      Date:
      March 2, 2016
      Source:
      American Academy of Orthopaedic Surgeons
      Summary:
      Injections received in the months prior to total knee or total hip replacement surgery may increase the risk for infection and related complications, according to two new studies — among the largest conducted on this topic.

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.